Skip to main content

Table 1 Baseline characteristics of study participants according to quartiles of Cre/BW ratio

From: Creatinine-to-body weight ratio is a predictor of incident diabetes: a population-based retrospective cohort study

 

Overall

Q1(< 1.062)

Q2 (≥ 1.062 to < 1.219)

Q3 (≥ 1.219 to < 1.396)

Q4 (≥ 1.396)

P-value

Number

200,658

50,165

50,164

50,163

50,166

 

Age (years)

42.24 ± 12.73

42.37 ± 11.69

42.11 ± 12.04

41.98 ± 12.67

42.50 ± 14.35

 < 0.001

Height (cm)

166.50 ± 8.33

166.61 ± 8.68

166.63 ± 8.46

166.62 ± 8.23

166.13 ± 7.91

 < 0.001

Weight (kg)

64.75 ± 12.23

70.98 ± 13.54

65.75 ± 11.73

63.08 ± 10.72

59.18 ± 9.40

 < 0.001

BMI (kg/m2)

23.24 ± 3.34

25.43 ± 3.50

23.55 ± 2.95

22.62 ± 2.80

21.38 ± 2.66

 < 0.001

SBP (mmHg)

119.04 ± 16.40

121.38 ± 16.81

118.77 ± 16.25

118.03 ± 15.90

117.98 ± 16.41

 < 0.001

DBP (mmHg)

74.16 ± 10.81

75.65 ± 11.31

74.20 ± 10.83

73.68 ± 10.54

73.11 ± 10.36

 < 0.001

FPG (mmol/L)

4.91 ± 0.61

4.99 ± 0.62

4.91 ± 0.61

4.88 ± 0.61

4.87 ± 0.61

 < 0.001

TC (mmol/L)

4.72 ± 0.89

4.79 ± 0.91

4.73 ± 0.89

4.70 ± 0.89

4.64 ± 0.88

 < 0.001

TG (mmol/L)

1.34 ± 1.03

1.51 ± 1.22

1.37 ± 1.04

1.30 ± 0.95

1.20 ± 0.83

 < 0.001

Cre/BW ratio (× 100)

1.24 ± 0.27

0.94 ± 0.10

1.14 ± 0.04

1.30 ± 0.05

1.59 ± 0.22

 < 0.001

HDL-C (mmol/L)

1.37 ± 0.23

1.36 ± 0.23

1.37 ± 0.23

1.38 ± 0.24

1.38 ± 0.23

 < 0.001

LDL (mmol/L)

2.77 ± 0.52

2.79 ± 0.53

2.77 ± 0.52

2.77 ± 0.52

2.75 ± 0.51

 < 0.001

ALT (U/L)

23.99 ± 21.98

27.78 ± 25.98

24.53 ± 22.77

22.96 ± 21.36

20.68 ± 16.03

 < 0.001

AST (U/L)

24.11 ± 7.95

24.53 ± 7.84

24.12 ± 8.34

23.96 ± 7.43

23.82 ± 8.15

 < 0.001

BUN (mmol/L)

4.66 ± 1.15

4.44 ± 1.10

4.58 ± 1.11

4.70 ± 1.12

4.92 ± 1.22

 < 0.001

Cre (mg/dl)

0.79 ± 0.18

0.66 ± 0.13

0.75 ± 0.14

0.82 ± 0.14

0.94 ± 0.18

 < 0.001

Develop T2DM

     

 < 0.001

 No

196,657 (98.01)

48,542 (96.76)

49,175 (98.03)

49,388 (98.46)

49,552 (98.78)

 

 Yes

4001 (1.99)

1623 (3.24)

989 (1.97)

775 (1.54)

614 (1.22)

 

Sex (%)

     

 < 0.001

 Men

110,431 (55.03)

20,467 (40.8)

25,616 (51.06)

29,599 (59.01)

34,749 (69.27)

 

 Women

90,227 (44.97)

29,698 (59.2)

24,548 (48.94)

20,564 (40.99)

15,417 (30.73)

 

Smoking status (%)

     

 < 0.001

 Current

11,373 (5.67)

2421 (4.83)

2817 (5.62)

2964 (5.91)

3171 (6.32)

 

 Ever

2473 (1.23)

505 (1.01)

596 (1.19)

677 (1.35)

695 (1.39)

 

 Never

43,816 (21.84)

10,504 (20.94)

10,942 (21.81)

11,015 (21.96)

11,355 (22.63)

 

 No recorded

142,996 (71.26)

36,735 (73.23)

35,809 (71.38)

35,507 (70.78)

34,945 (69.66)

 

Drinking status (%)

     

 < 0.001

 Current

1284 (0.64)

292 (0.58)

344 (0.69)

354 (0.71)

294 (0.59)

 

 Ever

8649 (4.31)

1764 (3.52)

2110 (4.21)

2363 (4.71)

2412 (4.81)

 

 Never

47,729 (23.79)

11,374 (22.67)

11,901 (23.72)

11,939 (23.8)

12,515 (24.95)

 

 No recorded

142,996 (71.26)

36,735 (73.23)

35,809 (71.38)

35,507 (70.78)

34,945 (69.66)

 

Family history of diabetes (%)

     

 < 0.001

 No

196,452 (97.90)

48,785 (97.25)

49,059 (97.8)

49,193 (98.07)

49,415 (98.5)

 

 Yes

4206 (2.10)

1380 (2.75)

1105 (2.2)

970 (1.93)

751 (1.5)

 
  1. BMI body mass index, HDL-C high-density lipoprotein cholesterol, LDL low density lipoprotein, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, SBP systolic blood pressure, DBP diastolic blood pressure, Cre/BW creatinine to body weight, Cre concentration of creatinine, AST aspartate aminotransferase, ALT alanine aminotransferase, BUN blood urea nitrogen, T2DM type 2 diabetes mellitus, CI confidence interval, HR hazard ratio